Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Take A Stand for Workplace Health: A Sit-stand Workstation Project Evaluation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02172599
Recruitment Status : Completed
First Posted : June 24, 2014
Last Update Posted : January 18, 2018
Sponsor:
Collaborators:
Macmillan Canceer Support
Ergotron
Public Health England
Information provided by (Responsible Party):
Jennifer Hall, Brunel University

Tracking Information
First Submitted Date  ICMJE June 22, 2014
First Posted Date  ICMJE June 24, 2014
Last Update Posted Date January 18, 2018
Actual Study Start Date  ICMJE May 2014
Actual Primary Completion Date February 2016   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: January 27, 2015)
Physical Activity [ Time Frame: Measured 5 times over 13 months, for seven days each time. Time points = baseline, 1-2weeks, 3 months, 6 months and 12 months ]
ActivPAL: Sitting and standing will be measured objectively using the ActivPAL device. The ActivPAL provides reliable measures of total sitting time and standing time, and number of sit-to-stand transitions per hour (Lyden et al. 2012). ActiGraph (GT3X+): Physical activity intensity and duration will be measured objectively using the ActiGraph activity monitor.The GT3X reliably classifies physical activity intensity in free-living environments (Ozemek et al. 2014). Activity diaries: These dairies will be used to assess the type and context of physical activity behaviour. A text reminder will be sent to all participants once daily for the duration of the data collection period. Text message models have shown some success in increasing compliance to research (Armstrong et al. 2009).
Original Primary Outcome Measures  ICMJE
 (submitted: June 22, 2014)
Physical Activity [ Time Frame: Measured 6 times over 13 months, for seven days each time. Time points = baseline, 1-2weeks, 3 months, 6 months, 9 months and 12 months ]
ActivPAL Sitting and standing will be measured objectively using the ActivPAL device. The ActivPAL provides reliable measures of total sitting time and standing time, and number of sit-to-stand transitions per hour (Lyden et al. 2012). ActiGraph (GT3X+) Physical activity intensity and duration will be measured objectively using the ActiGraph activity monitor.The GT3X reliably classifies physical activity intensity in free-living environments (Ozemek et al. 2014). Participant Diaries Activity dairies will be used to assess the type and context of physical activity behaviour. A text reminder will be sent to all participants once daily for the duration of the data collection period. Text message models have shown some success in increasing compliance to research (Armstrong et al. 2009).
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Take A Stand for Workplace Health: A Sit-stand Workstation Project Evaluation
Official Title  ICMJE The Influence of Sit-stand Workstations Upon Total Physical Activity: a 12 Month Randomised Controlled Trial
Brief Summary The purpose of this study is to examine the contribution of sit-stand workstations to total daily physical activity in a multi-component office-based 12 month intervention.
Detailed Description This study adopts a randomised control trial design and is mixed methods (qualitative and quantitative). The outcome data from the trial is quantitative. Alongside this a qualitative process evaluation will be conducted to inform the intervention, explain trial results and understand the intervention implementation and context (Cathain et al. 2014). Two worksites will participate in this study, in line with COCHRANE recommendations for randomised control trials.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Condition  ICMJE Physical Activity
Intervention  ICMJE Behavioral: Sit-stand workstation provision
The research compares the effects of a sit-stand workstation only and a multi-component sit-stand workstation intervention including individual and organisation-level approaches, with usual office-based working practice (no sit-stand workstation) over 12 months.
Other Name: Ergotron: workfit-A, workfit-D
Study Arms  ICMJE
  • Experimental: multi-component intervention

    Sit-stand workstation provision

    The multi-component intervention will align with the World Health Authority's promotion of a healthy workplace model, which emphasises that best-practice workplace health interventions should involve an integrated approach involving organisation and individual level approaches to behaviour change (WHO, 2010). Thus, participants will receive a sit-stand workstation with additional support to use the sit-stand workstation.

    Intervention: Behavioral: Sit-stand workstation provision
  • Experimental: Sit-stand workstation only

    Sit-stand workstation provision

    Participants in this arm will receive a sit-stand workstation. They will not receive any support to use the sit-stand workstation, except some health and safety advice upon installation.

    Intervention: Behavioral: Sit-stand workstation provision
  • No Intervention: Usual practice (seated workstation)
    This arm is the control group. They will continue to use their usual seated workstation for the duration of the study.
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: June 22, 2014)
30
Original Estimated Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE February 2016
Actual Primary Completion Date February 2016   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Must be a full-time employee on a fixed term contract for at least 18 months at one of the two worksites involved in the study (Macmillan Cancer Support, Public Health England)
  • Must engage in primarily desk-based work
  • Must have their own desk (i.e. does not hot desk) Must be primarily office based (i.e. not working from home)
  • Must have no plans to leave the organisation for an extended period (e.g. holiday > 4 weeks or secondment) or finitely before the anticipated study end date (January 2016)

Exclusion Criteria:

  • Have engaged in standing-based desk work in the month prior to the start of the study
  • Have been advised against standing by a health professional; or be unable to stand
  • Work for the Macmillan Support Line
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United Kingdom
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT02172599
Other Study ID Numbers  ICMJE TSWH
R33134 ( Other Grant/Funding Number: Macmillan Cancer Support )
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Jennifer Hall, Brunel University
Study Sponsor  ICMJE Brunel University
Collaborators  ICMJE
  • Macmillan Canceer Support
  • Ergotron
  • Public Health England
Investigators  ICMJE
Principal Investigator: Jennifer Hall, BSc Brunel University
PRS Account Brunel University
Verification Date January 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP